RET and neoplasm: In contrast to results obtained in 3D in vitro assays, RET inhibition and letrozole treatment as monotherapies showed comparable effects in impairing xenograft growth and, moreover, the combination of NVP-AST487 and letrozole had no additional effect on tumor growth (Figure 4A).